Related references
Note: Only part of the references are listed.Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway
Fangying Yan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer
Guang Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang et al.
CANCER RESEARCH AND TREATMENT (2020)
YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma
Jingxia Han et al.
CANCER RESEARCH (2019)
Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks
Paria Abedini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
Nadia Marascio et al.
CELLS (2019)
lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis
Min Hu et al.
MOLECULAR CARCINOGENESIS (2019)
A long noncoding RNA binding to QKI-5 regulates germ cell apoptosis via p38 MAPK signaling pathway
Kai Li et al.
CELL DEATH & DISEASE (2019)
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Ling Wei et al.
MOLECULAR CANCER (2019)
Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
Chun Yang et al.
BMC MOLECULAR AND CELL BIOLOGY (2019)
LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
Hai Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
Shashi Kumar Gupta et al.
CIRCULATION RESEARCH (2018)
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
Yuan Jiang et al.
NATURE COMMUNICATIONS (2018)
Emerging connections between RNA and autophagy
Lisa B. Frankel et al.
AUTOPHAGY (2017)
Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells
Xin Yin et al.
GENE (2017)
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway
Yaling Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
H. Xiong et al.
ONCOGENE (2017)
LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma
Jia Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
被撤回的出版物: LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis (Retracted article. See vol. 22, pg. 144, 2023)
Qiaosu Wang et al.
CELL CYCLE (2017)
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4
Baoli Hu et al.
CANCER BIOLOGY & THERAPY (2017)
RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA
Rui-Li Zhang et al.
CELL CYCLE (2016)
Systemic Therapy of Hepatocellular Carcinoma Current and Promising
Aparna Kalyan et al.
CLINICS IN LIVER DISEASE (2015)
QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway
X. Fu et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2015)
Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge
Liang Deng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
The tumor suppressing effects of QKI-5 in prostate cancer A novel diagnostic and prognostic protein
Yi Zhao et al.
CANCER BIOLOGY & THERAPY (2014)
Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy
Kenji Takahashi et al.
MOLECULAR CANCER RESEARCH (2014)
Post- transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells
Fang Yu et al.
ONCOLOGY REPORTS (2014)
DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
M. R. Salehan et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2013)
Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Ethan B. Butler et al.
CANCER RESEARCH (2013)
Clinical Trials in Hepatocellular Carcinoma: An Update
Ying-Chun Shen et al.
Liver Cancer (2013)
Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells
W. P. Tsang et al.
ONCOGENE (2007)
Share Paper
